Hemostatic considerations for gender affirming care
Thrombosis Research · 2023-10 · 230 · 126-132
DOI: 10.1016/j.thromres.2023.09.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Thrombosis Research, 2023-10. Verfasst von Kathleen Garland und 5 weiteren Autor:innen. Beteiligte Einrichtung: Children's Minnesota, Minneapolis, MN 55404, United States of America. Electronic address: kate.garland@childrensmn.org. Hauptthemen laut MEDLINE: Hemostatics, Transgender Persons. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben.
Abstract (Originalsprache)
Gender dysphoria or gender incongruence is defined as "persons that are not satisfied with their designated gender" [1]. The awareness and evidence-based treatment options available to this population have grown immensely over the last two decades. Protocols now include an Endocrine Society Clinical Practice Guideline [1] as well as the World Professional Association of Transgender Health Standards of Care (WPATH SOC) [2]. Hematologic manifestations, most notably thrombosis, are one of the most recognized adverse reactions to the hormones used for gender-affirming care. Therefore, hematologists are frequently consulted prior to initiation of hormonal therapy to help guide safe treatment. This review will focus on the scientific evidence related to hemostatic considerations for various gender-affirming therapies and serve as a resource to assist in medical decision-making among providers and patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children's Minnesota, Minneapolis, MN 55404, United States of America. Electronic address: kate.garland@childrensmn.org.
- Cincinnati Children's Hospital Medical Center and University of Cincinnati-College of Medicine, Cincinnati, OH 45229, United States of America.
- Ann & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States of America.
- Nationwide Children's Hospital, The Ohio State University, Columbus, OH 43205, United States of America.
- Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA 02115, United States of America.
- Children's Healthcare of Atlanta, Atlanta, GA 30308, United States of America.
Zitieren
APA
Garland, K., Mullins, E., Bercovitz, R. S., Rodriguez, V., Connors, J., & Sokkary, N. (2023). Hemostatic considerations for gender affirming care. Thrombosis Research, 230, 126-132. https://doi.org/10.1016/j.thromres.2023.09.002
Vancouver
Garland K, Mullins E, Bercovitz RS, Rodriguez V, Connors J, Sokkary N. Hemostatic considerations for gender affirming care. Thrombosis Research. 2023;230:126-132. doi:10.1016/j.thromres.2023.09.002
BibTeX
@article{Garland2023,
author = {Garland, Kathleen and Mullins, Eric and Bercovitz, Rachel S and Rodriguez, Vilmarie and Connors, Jean and Sokkary, Nancy},
title = {Hemostatic considerations for gender affirming care},
journal = {Thrombosis Research},
year = {2023},
volume = {230},
pages = {126--132},
doi = {10.1016/j.thromres.2023.09.002}
}
EUVIMED